Dr. Noah Biotech
DR.NOAH BIOTECH is a next-generation pharmaceutical company focused on efficient drug development, leveraging big data analytics and artificial intelligence. They aim to develop treatments for rare genetic diseases, recognizing the significant unmet need in this market. The company's core technology allows for efficient drug prediction, with the capability to identify rare disease treatments within three months, a stark contrast to the estimated 500 years it would take with traditional methods. They specialize in predicting drug combinations using existing drugs that target multifactorial mechanisms. This approach aims to maximize therapeutic effects while reducing development time and costs. Their AI platform, ARK, is designed for various tasks including early drug combination prediction, cellular phenotype-based efficacy evaluation, and prediction of drug-drug interaction risks. DR.NOAH BIOTECH is collaborating with global companies like Dassault Systemes and Korean companies like Daewoong Pharmaceutical and Amorepacific to advance their platform and drug development.
Dr. Noah Biotech
DR.NOAH BIOTECH is a next-generation pharmaceutical company focused on efficient drug development, leveraging big data analytics and artificial intelligence. They aim to develop treatments for rare genetic diseases, recognizing the significant unmet need in this market. The company's core technology allows for efficient drug prediction, with the capability to identify rare disease treatments within three months, a stark contrast to the estimated 500 years it would take with traditional methods. They specialize in predicting drug combinations using existing drugs that target multifactorial mechanisms. This approach aims to maximize therapeutic effects while reducing development time and costs. Their AI platform, ARK, is designed for various tasks including early drug combination prediction, cellular phenotype-based efficacy evaluation, and prediction of drug-drug interaction risks. DR.NOAH BIOTECH is collaborating with global companies like Dassault Systemes and Korean companies like Daewoong Pharmaceutical and Amorepacific to advance their platform and drug development.